CH argenteuil — Argenteuil

Public research footprint of CH argenteuil, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Community-acquired Pneumonia, Influenza, COVID-19 · Multiple Myeloma · Ventilator-Associated Pneumonia (VAP) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Recently updated registry entries

NCT06015529 — Diagnostic Strategy for Suspected Pulmonary Embolism Based on 4PEPS (Completed)
NCT02896842 — A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate… (Completed)
NCT04481529 — COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CH argenteuil?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.